Literature DB >> 32410140

Proto-oncogene Zbtb7a represses miR-125a-5p transcription in hepatocellular carcinoma cells.

Armando Di Palo1, Chiara Siniscalchi1, Nicola Mosca2, Aniello Russo3, Nicoletta Potenza4.   

Abstract

Zbtb7a is a transcription factor whose dysfunction is correlated to the development of several types of cancer, including hepatocellular carcinoma (HCC). It generally acts as a repressor of transcription downregulating the expression of several target genes including oncosuppressors ARF and Rb. In this study, Zbtb7a was found to suppress the expression of miR-125a, an oncosuppressive miRNA that is often downregulated in HCC. This effect is mediated by the binding of the transcription factor to a regulatory sequence in the promoter of the transcription unit of miR-125a located 14 bp upstream of the transcription start site. Consistent with this observation, the analysis of 370 HCC samples showed an upregulation of Zbtb7a compared to 50 normal liver tissues and a reverse correlation with miR-125a expression. These data suggest that miR-125a may support the oncogenic potential of Zbtb7a.

Entities:  

Keywords:  Cancer; Cell proliferation; Hepatocarcinoma; Transcription factor; microRNA

Mesh:

Substances:

Year:  2020        PMID: 32410140     DOI: 10.1007/s11033-020-05512-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  2 in total

1.  A Novel ceRNA Regulatory Network Involving the Long Non-Coding Antisense RNA SPACA6P-AS, miR-125a and its mRNA Targets in Hepatocarcinoma Cells.

Authors:  Armando Di Palo; Chiara Siniscalchi; Nicola Mosca; Aniello Russo; Nicoletta Potenza
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

2.  LncRNA MIR4435-2HG functions as a ceRNA against miR-125a-5p and promotes neuroglioma development by upregulating TAZ.

Authors:  Wangzhen Shen; Jiawei Zhang; Yunfeng Pan; Yun Jin
Journal:  J Clin Lab Anal       Date:  2021-10-29       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.